3rd Quarter - Report
COREWELL HEALTH for COREWELL HEALTH
Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health system financial challenges. Drug discount program under section 340B of the Public Health Service Act. Development of AI policies and regulations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA KO | — |
| PHILIP D YEITER | — |
Medicare/Medicaid MMM
Site neutral policies Medicare Telehealth Reimbursement Physician Fee Schedule
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA KO | — |
| PHILIP D YEITER | — |
Pharmacy PHA
340B PBM Reform/Oversight Transparency and high costs associated with prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA KO | — |
| PHILIP D YEITER | — |
Labor Issues/Antitrust/Workplace LBR
Workforce Shortage within Healthcare Industry S. 3744 Health ACCESS Act Talent Pipeline
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTINA KO | — |
| PHILIP D YEITER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.